Rare Endocrine Disease Treatment

Global Market Trajectory & Analytics

MCP14355

EXECUTIVE ENGAGEMENTS

* Login for a full stack data experience

DATE

JUL 2020

TABLES

111

182

EDITION

6

PRICE

USD $4950

Amid the COVID-19 crisis, the global market for Rare Endocrine Disease Treatment estimated at US$8.9 Billion in the year 2020, is projected to reach a revised size of US$11.5 Billion by 2027, growing at a CAGR of 3.6% over the analysis period 2020-2027. Acromegaly, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$4.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Central Diabetes Insipidus segment is readjusted to a revised 3.4% CAGR for the next 7-year period.

The Rare Endocrine Disease Treatment market in the U.S. is estimated at US$2.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2027 trailing a CAGR of 3.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

In the global Ahumada-Del Castillo Syndrome segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$960.1 Million in the year 2020 will reach a projected size of US$1.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027.We bring years of research experience to this 6th edition of our report. The 182-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

SELECT PLAYERS

Amgen, Inc.; Corcept Therapeutics, Inc.; Eli Lilly and Company; EMD Serono, Inc.; Ipsen Group; Novartis AG; Novelion Therapeutics, Inc.; Novo Nordisk A/S; Pfizer, Inc.; Shire PLC; Teva Pharmaceutical Industries Ltd.

SEGMENTS

» Administration (Injectables, Oral, Other Administrations) » Indication (Acromegaly, Central Diabetes Insipidus, Ahumada-Del Castillo Syndrome, Hypoparathyroidism, Other Indications)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Rare Endocrine Disease Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Rare Endocrine Disease Treatment Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Rare Endocrine Disease Treatment Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
Rare Endocrine Disease Treatment Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Acromegaly (Indication) World Market by Region/Country in US$ Million: 2018 to 2025
Acromegaly (Indication) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Acromegaly (Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Central Diabetes Insipidus (Indication) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
Central Diabetes Insipidus (Indication) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
Central Diabetes Insipidus (Indication) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Ahumada-Del Castillo Syndrome (Indication) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
Ahumada-Del Castillo Syndrome (Indication) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
Ahumada-Del Castillo Syndrome (Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Hypoparathyroidism (Indication) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
Hypoparathyroidism (Indication) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
Hypoparathyroidism (Indication) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
Other Indications (Indication) World Market by Region/Country in US$ Million: 2018 to 2025
Other Indications (Indication) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Other Indications (Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Injectables (Administration) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
Injectables (Administration) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
Injectables (Administration) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
Oral (Administration) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
Oral (Administration) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
Oral (Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Other Administrations (Administration) World Market by Region/Country in US$ Million: 2018 to 2025
Other Administrations (Administration) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Other Administrations (Administration) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Rare Endocrine Disease Treatment Market Share (in %) by Company: 2019 & 2025
United States Rare Endocrine Disease Treatment Market Estimates and Projections in US$ Million by Indication: 2018 to 2025
Rare Endocrine Disease Treatment Market in the United States by Indication: A Historic Review in US$ Million for 2009-2017
United States Rare Endocrine Disease Treatment Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
United States Rare Endocrine Disease Treatment Market Estimates and Projections in US$ Million by Administration: 2018 to 2025
Rare Endocrine Disease Treatment Market in the United States by Administration: A Historic Review in US$ Million for 2009-2017
United States Rare Endocrine Disease Treatment Market Share Breakdown by Administration: 2009 VS 2019 VS 2025
CANADA
Canadian Rare Endocrine Disease Treatment Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025
Canadian Rare Endocrine Disease Treatment Historic Market Review by Indication in US$ Million: 2009-2017
Rare Endocrine Disease Treatment Market in Canada: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025
Canadian Rare Endocrine Disease Treatment Market Estimates and Forecasts in US$ Million by Administration: 2018 to 2025
Canadian Rare Endocrine Disease Treatment Historic Market Review by Administration in US$ Million: 2009-2017
Rare Endocrine Disease Treatment Market in Canada: Percentage Share Breakdown of Sales by Administration for 2009, 2019, and 2025
JAPAN
Japanese Market for Rare Endocrine Disease Treatment: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025
Rare Endocrine Disease Treatment Market in Japan: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017
Japanese Rare Endocrine Disease Treatment Market Share Analysis by Indication: 2009 VS 2019 VS 2025
Japanese Market for Rare Endocrine Disease Treatment: Annual Sales Estimates and Projections in US$ Million by Administration for the Period 2018-2025
Rare Endocrine Disease Treatment Market in Japan: Historic Sales Analysis in US$ Million by Administration for the Period 2009-2017
Japanese Rare Endocrine Disease Treatment Market Share Analysis by Administration: 2009 VS 2019 VS 2025
CHINA
Chinese Rare Endocrine Disease Treatment Market Growth Prospects in US$ Million by Indication for the Period 2018-2025
Rare Endocrine Disease Treatment Historic Market Analysis in China in US$ Million by Indication: 2009-2017
Chinese Rare Endocrine Disease Treatment Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
Chinese Rare Endocrine Disease Treatment Market Growth Prospects in US$ Million by Administration for the Period 2018-2025
Rare Endocrine Disease Treatment Historic Market Analysis in China in US$ Million by Administration: 2009-2017
Chinese Rare Endocrine Disease Treatment Market by Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Rare Endocrine Disease Treatment Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Rare Endocrine Disease Treatment Market Demand Scenario in US$ Million by Region/Country: 2018-2025
Rare Endocrine Disease Treatment Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European Rare Endocrine Disease Treatment Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European Rare Endocrine Disease Treatment Market Estimates and Forecasts in US$ Million by Indication: 2018-2025
Rare Endocrine Disease Treatment Market in Europe in US$ Million by Indication: A Historic Review for the Period 2009-2017
European Rare Endocrine Disease Treatment Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
European Rare Endocrine Disease Treatment Market Estimates and Forecasts in US$ Million by Administration: 2018-2025
Rare Endocrine Disease Treatment Market in Europe in US$ Million by Administration: A Historic Review for the Period 2009-2017
European Rare Endocrine Disease Treatment Market Share Breakdown by Administration: 2009 VS 2019 VS 2025
FRANCE
Rare Endocrine Disease Treatment Market in France by Indication: Estimates and Projections in US$ Million for the Period 2018-2025
French Rare Endocrine Disease Treatment Historic Market Scenario in US$ Million by Indication: 2009-2017
French Rare Endocrine Disease Treatment Market Share Analysis by Indication: 2009 VS 2019 VS 2025
Rare Endocrine Disease Treatment Market in France by Administration: Estimates and Projections in US$ Million for the Period 2018-2025
French Rare Endocrine Disease Treatment Historic Market Scenario in US$ Million by Administration: 2009-2017
French Rare Endocrine Disease Treatment Market Share Analysis by Administration: 2009 VS 2019 VS 2025
GERMANY
Rare Endocrine Disease Treatment Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
German Rare Endocrine Disease Treatment Historic Market Analysis in US$ Million by Indication: 2009-2017
German Rare Endocrine Disease Treatment Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
Rare Endocrine Disease Treatment Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Administration for the Period 2018-2025
German Rare Endocrine Disease Treatment Historic Market Analysis in US$ Million by Administration: 2009-2017
German Rare Endocrine Disease Treatment Market Share Breakdown by Administration: 2009 VS 2019 VS 2025
ITALY
Italian Rare Endocrine Disease Treatment Market Growth Prospects in US$ Million by Indication for the Period 2018-2025
Rare Endocrine Disease Treatment Historic Market Analysis in Italy in US$ Million by Indication: 2009-2017
Italian Rare Endocrine Disease Treatment Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
Italian Rare Endocrine Disease Treatment Market Growth Prospects in US$ Million by Administration for the Period 2018-2025
Rare Endocrine Disease Treatment Historic Market Analysis in Italy in US$ Million by Administration: 2009-2017
Italian Rare Endocrine Disease Treatment Market by Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
United Kingdom Market for Rare Endocrine Disease Treatment: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025
Rare Endocrine Disease Treatment Market in the United Kingdom: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017
United Kingdom Rare Endocrine Disease Treatment Market Share Analysis by Indication: 2009 VS 2019 VS 2025
United Kingdom Market for Rare Endocrine Disease Treatment: Annual Sales Estimates and Projections in US$ Million by Administration for the Period 2018-2025
Rare Endocrine Disease Treatment Market in the United Kingdom: Historic Sales Analysis in US$ Million by Administration for the Period 2009-2017
United Kingdom Rare Endocrine Disease Treatment Market Share Analysis by Administration: 2009 VS 2019 VS 2025
REST OF EUROPE
Rest of Europe Rare Endocrine Disease Treatment Market Estimates and Forecasts in US$ Million by Indication: 2018-2025
Rare Endocrine Disease Treatment Market in Rest of Europe in US$ Million by Indication: A Historic Review for the Period 2009-2017
Rest of Europe Rare Endocrine Disease Treatment Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
Rest of Europe Rare Endocrine Disease Treatment Market Estimates and Forecasts in US$ Million by Administration: 2018-2025
Rare Endocrine Disease Treatment Market in Rest of Europe in US$ Million by Administration: A Historic Review for the Period 2009-2017
Rest of Europe Rare Endocrine Disease Treatment Market Share Breakdown by Administration: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Rare Endocrine Disease Treatment Market in Asia-Pacific by Indication: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Rare Endocrine Disease Treatment Historic Market Scenario in US$ Million by Indication: 2009-2017
Asia-Pacific Rare Endocrine Disease Treatment Market Share Analysis by Indication: 2009 VS 2019 VS 2025
Rare Endocrine Disease Treatment Market in Asia-Pacific by Administration: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Rare Endocrine Disease Treatment Historic Market Scenario in US$ Million by Administration: 2009-2017
Asia-Pacific Rare Endocrine Disease Treatment Market Share Analysis by Administration: 2009 VS 2019 VS 2025
REST OF WORLD
Rest of World Rare Endocrine Disease Treatment Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025
Rest of World Rare Endocrine Disease Treatment Historic Market Review by Indication in US$ Million: 2009-2017
Rare Endocrine Disease Treatment Market in Rest of World: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025
Rest of World Rare Endocrine Disease Treatment Market Estimates and Forecasts in US$ Million by Administration: 2018 to 2025
Rest of World Rare Endocrine Disease Treatment Historic Market Review by Administration in US$ Million: 2009-2017
Rare Endocrine Disease Treatment Market in Rest of World: Percentage Share Breakdown of Sales by Administration for 2009, 2019, and 2025
IV. COMPETITION
Total Companies Profiled : 41
Click here to request a full table of contents and more details on this project.
V. CURATED RESEARCH

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

Complimentary previews of full stack research data for participated

Insider access to research programs including engagements and stats from other panelists

Unlimited research credits of $1000 per participated project

Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company

Interact with other panelists via our MarketGlass^TM Data Exchange Platform*

BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

GLOBAL EXPERT PANEL